UK becomes the first country to approve the Pfizer vaccine as well as the first western country to approve a vaccine against COVID-19.
London: The United Kingdom has approved the Pfizer-BioNTech vaccine for rollout from ‘next week’, AFP reported on Wednesday, 2 December.
Pfizer and BioNTech had earlier applied to the European drugs regulator for conditional authorisation of their shot.
No safety concerns, Vaccine is 95% effective in final trials: Pfizer
United States’ Pfizer and Germany’s BioNTech, according to Reuters, reported final trial results on 18 November that showed that their vaccine candidate was 95 percent effective in preventing COVID-19.
According to ANI, a statement from the company says “The Phase 3 study of our COVID-19 vaccine candidate has met all primary efficacy endpoints. The study reached 170 confirmed cases of COVID19, with the vaccine candidate BNT162b2 demonstrating 95 percent efficacy beginning 28 days after the first dose.
The trial data showed the vaccine had equal efficacy among younger volunteers and those over 65 who are most at risk from Covid. Gender, race and ethnicity also made no difference.
Pfizer and BioNTech say their combined manufacturing network has the potential to supply globally up to 50m vaccine doses in 2020 and up to 1.3bn doses by the end of 2021.